BioNTech SE (BNTX)
86.50
+1.00
(+1.17%)
USD |
NASDAQ |
Jun 09, 16:00
84.69
-1.81
(-2.09%)
After-Hours: 07:39
BioNTech EPS Diluted (Quarterly) : -2.461 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Moderna, Inc. | -3.40 |
| NuCana Plc | -1.28 |
| MediGene AG | -- |
| InflaRx NV | -0.0905 |
| Mereo BioPharma Group Plc | -0.0418 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -622.28M |
| Revenue (Quarterly) | 138.17M |
| Total Expenses (Quarterly) | 760.45M |
| Enterprise Value | 5.359B |
| Gross Profit Margin (Quarterly) | -63.17% |
| Profit Margin (Quarterly) | -450.4% |
| Earnings Yield | -6.79% |
| Normalized Earnings Yield | -3.846 |